Financials
- Market Capitalization 28.36 M
- Employee 28
- Founded 1996
- CEO N/A
- Website www.plustherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000C1Z086
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4477 | SNTI Senti Biosciences, Inc. - Common Stock | 0.74 USD | -23.71% | -28.16% | -22.92% | -22.27% | 23.05 M USD | ||
| 4487 | KYNB Kyntra Bio, Inc. - Common Stock | 7.37 USD | +0.68% | -2.90% | +4.69% | -22.50% | 29.83 M USD | ||
| 4492 | GNTA Genenta Science S.p.A. - American Depositary Shares | 1.43 USD | +14.40% | -6.54% | -18.75% | -59.26% | 33.51 M USD | ||
| 4494 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 3.18 USD | +2.58% | +1.27% | +20.91% | -11.67% | 29.83 M USD |
Frequently asked questions about PLUS THERAPEUTICS, Inc. - Common Stock
What is the PLUS THERAPEUTICS, Inc. - Common Stock stock price today?
The current price of PLUS THERAPEUTICS, Inc. - Common Stock (PSTV) is 4.12. Over the past 24 hours, the stock has changed by -3.74%. Follow the PSTV chart for real-time price dynamics.
What is the stock ticker of PLUS THERAPEUTICS, Inc. - Common Stock?
PLUS THERAPEUTICS, Inc. - Common Stock trades under the ticker PSTV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PLUS THERAPEUTICS, Inc. - Common Stock stock going up?
PSTV has changed by +6.19% over the last week, -15.05% over the last month, and +1187.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was PLUS THERAPEUTICS, Inc. - Common Stock net income for the last quarter?
PLUS THERAPEUTICS, Inc. - Common Stock reported net income of -6.95 M for the last quarter. The previous quarter showed -5.71 M, which means net income changed by -21.58%.
How many employees does PLUS THERAPEUTICS, Inc. - Common Stock have?
As of the latest available data, PLUS THERAPEUTICS, Inc. - Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.
What is PLUS THERAPEUTICS, Inc. - Common Stock EBITDA?
PLUS THERAPEUTICS, Inc. - Common Stock EBITDA is -7.02 M, and its EBITDA margin is -683.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PLUS THERAPEUTICS, Inc. - Common Stock stock?
You can buy PLUS THERAPEUTICS, Inc. - Common Stock (PSTV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PLUS THERAPEUTICS, Inc. - Common Stock stock?
Investing in PLUS THERAPEUTICS, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PSTV chart and related analysis on metatrader.com as part of your research.